Investor Presentaiton

www.trulieve.com Third Quarter 2023 Financial and Operational Highlights* . Revenue $275 million, with 96% revenue from retail sales . GAAP gross profit of $143 million and 52% gross margin, improved by 2% sequentially SG&A expenses of $94 million, lowered by $2 million sequentially Net loss of $25 million Adjusted net loss of $15 million excludes non-recurring charges, disposals and discontinued operations EBITDA of $74 million or 27% of revenue and Adjusted EBITDA of $78 million or 28% of revenue Cash flow from operations of $93 million Free cash flow of $87 million Generated cash flow from operations excluding tax payments of $184 million year to date Purchased $57 million face value senior secured 2026 notes for $47.6 million, which represents a 16.5% discount to par, plus accrued interest Opened dispensaries in Pace and Sanford, FL, Evans and Pooler, GA, and Columbus, OH Relocated one dispensary in Kissimmee, FL * Adjusted net loss, adjusted EBITDA, and free cash flow are Non-GAAP financial measures. See slides 14-16 for reconciliation to GAAP for all Non-GAAP financial measures. Numbers may not sum perfectly due to rounding. 5

View entire presentation